Skip to content

Efficacy and safety of lemborexant in subjects previously treated with placebo for 6 months in a randomized phase 3 study.

Randomized controlled trial · Sleep Med · 2023. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 37574610

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Efficacy and safety of lemborexant in subjects previously treated with placebo for 6 months in a randomized phase 3 study.

Yardley J, Inoue Y, Pinner K et al.
Sleep Med · 2023

PubMed ID
37574610
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.